Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 23Terminated 11Recruiting 4Unknown 3Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 6Other hematologic neoplasm 5Lymphoid 4Genitourinary 1

Conditions

Prostatic Neoplasms 37Urinary Bladder Neoplasms 12Breast Neoplasms 7Neoplasms 6Kidney Neoplasms 5Carcinoma, Renal Cell 5Adenocarcinoma 5Carcinoma, Transitional Cell 4Stomach Neoplasms 3Ovarian Neoplasms 3Lung Neoplasms 3Heart Failure 3Disease 3Colorectal Neoplasms 3Anxiety Disorders 3Triple Negative Breast Neoplasms 2Pulmonary Disease, Chronic Obstructive 2Pancreatic Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Failure, Chronic 2Kidney Diseases 2Hematologic Neoplasms 2Cardiovascular Diseases 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Asthma 2von Hippel-Lindau Disease 1the Detection of Prostate Cancer in Men 1Uterine Cervical Neoplasms 1

Interventions

ibrutinib 1JNJ-64619178 1JNJ-64264681 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Myelodysplastic Syndromes × Genitourinary × Clear all
NCT06788509 2026-06-05

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Janssen Research & Development, LLC

Phase 1 Enrolling by invitation
120 enrolled
GenitourinaryLymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡